Team:NTNU Trondheim/Notebook/August
From 2012.igem.org
(→Monday 27.08.12) |
|||
(12 intermediate revisions not shown) | |||
Line 32: | Line 32: | ||
Also, Plld w/ RBS from ''E.coli'' was cut with S+P, Plld w/RBS from ''C.glutamicum'' was cut with E+P, and linearized plasmid backbone pSB1A3 was cut with E+P. The samples will be purified and ligated tomorrow. | Also, Plld w/ RBS from ''E.coli'' was cut with S+P, Plld w/RBS from ''C.glutamicum'' was cut with E+P, and linearized plasmid backbone pSB1A3 was cut with E+P. The samples will be purified and ligated tomorrow. | ||
+ | |||
+ | |||
+ | Results from the miniprep: | ||
+ | |||
+ | |||
+ | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" | ||
+ | !Gene | ||
+ | !Concentration [ng/µl] | ||
+ | |- | ||
+ | |P<sub>lld</sub>CGr+YFP+DTT in pSB1A3 #1 | ||
+ | |29,5 | ||
+ | |- | ||
+ | |P<sub>lld</sub>CGr+YFP+DTT in pSB1A3 #2 | ||
+ | |23,7 | ||
+ | |- | ||
+ | |P<sub>lld</sub>CGr+YFP+DTT in pSB1A3 #3 | ||
+ | |47,7 | ||
+ | |- | ||
+ | |P<sub>lld</sub>CGr+YFP+DTT in pSB1A3 #4 | ||
+ | |25,2 | ||
+ | |- | ||
+ | |P<sub>lld</sub>CGr+YFP+DTT in pSB13 #1 | ||
+ | |18,8 | ||
+ | |- | ||
+ | |P<sub>lld</sub>CGr+YFP+DTT in pSB1C3 #2 | ||
+ | |21,0 | ||
+ | |- | ||
+ | |P<sub>lld</sub>CGr in pSB1C3 2.1 | ||
+ | |24,8 | ||
+ | |- | ||
+ | |P<sub>lld</sub>CGr in pSB1C3 2.2 | ||
+ | |20,7 | ||
+ | |- | ||
+ | |P<sub>lld</sub>CGr in pSB1C3 3.1 | ||
+ | |21,3 | ||
+ | |- | ||
+ | |P<sub>lld</sub>CGr in pSB1C3 3.2 | ||
+ | |18,4 | ||
+ | |- | ||
+ | |} | ||
===Sunday 26.08.12=== | ===Sunday 26.08.12=== | ||
Line 43: | Line 83: | ||
Inoculated one cell culture of ''E.coli'' DH5α containing a plasmid consisting of RBS (<partinfo>BBa_B0030</partinfo>) + LacI (<partinfo>BBa_C0061</partinfo>) + DTT (<partinfo>BBa_B0014</partinfo>), and one cell culture consisting of ''E.coli'' DH5α cells without plasmid. These colonies will be used for real time PCR. | Inoculated one cell culture of ''E.coli'' DH5α containing a plasmid consisting of RBS (<partinfo>BBa_B0030</partinfo>) + LacI (<partinfo>BBa_C0061</partinfo>) + DTT (<partinfo>BBa_B0014</partinfo>), and one cell culture consisting of ''E.coli'' DH5α cells without plasmid. These colonies will be used for real time PCR. | ||
+ | |||
+ | ===Thursday 23.08.12=== | ||
+ | ---- | ||
+ | |||
+ | BBa_K822001 in pSB1A3 was cut with Spe1 and Pst1, BBa_E0030 + terminator was cut with Xba1 and PSt1. | ||
+ | |||
+ | BBa_E0030 + terminator was run on gel, and got the consentration 4,5 ng/uL. | ||
+ | |||
+ | BBa_K822001 in pSB1A3 was purified using a PCR purifying kit, and an concentration of 1,2 ng/uL was obtained. | ||
===Wednesday 22.08.12=== | ===Wednesday 22.08.12=== | ||
Line 49: | Line 98: | ||
P<sub>lld</sub> in pSB1A3 and pSB1C3 were miniprepped as described in the [https://2012.igem.org/Team:NTNU_Trondheim/Protocols protocol]. The concentrations are listed below. | P<sub>lld</sub> in pSB1A3 and pSB1C3 were miniprepped as described in the [https://2012.igem.org/Team:NTNU_Trondheim/Protocols protocol]. The concentrations are listed below. | ||
- | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" | |
- | {| class=" | + | |
!Gene | !Gene | ||
!Concentration [ng/µl] | !Concentration [ng/µl] | ||
Line 61: | Line 109: | ||
|- | |- | ||
|} | |} | ||
+ | |||
===Tuesday 21.08.12=== | ===Tuesday 21.08.12=== | ||
Line 69: | Line 118: | ||
The PCR mix and program are given below. | The PCR mix and program are given below. | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Substance | !Substance | ||
!Volume [µl] | !Volume [µl] | ||
Line 100: | Line 149: | ||
{| | {| | ||
| style="padding-right:7px;" | | | style="padding-right:7px;" | | ||
- | {|class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
! Step | ! Step | ||
! Action | ! Action | ||
Line 162: | Line 211: | ||
|} | |} | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Amplicon | !Amplicon | ||
!x<sub>1</sub> [°C] | !x<sub>1</sub> [°C] | ||
Line 191: | Line 240: | ||
The cells inoculated to liquid medium on saturday were miniprepped. The concentrations are given below, together with the volume necessary for obtaining 1000 ng of plasmid | The cells inoculated to liquid medium on saturday were miniprepped. The concentrations are given below, together with the volume necessary for obtaining 1000 ng of plasmid | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Biobrick | !Biobrick | ||
!Concentration [ng/µl] | !Concentration [ng/µl] | ||
Line 243: | Line 292: | ||
Vgb+RBS religated, Vgb+RBS+LuxR+DTT #1, Vgb+RBS+LuxR+DTT #2, LuxI+DTT, K+RBS+LacI+DTT and his-tagged LldR was miniprepped using the Promega SV miniprep kit. The concentrations of isolated plasmid are given below: | Vgb+RBS religated, Vgb+RBS+LuxR+DTT #1, Vgb+RBS+LuxR+DTT #2, LuxI+DTT, K+RBS+LacI+DTT and his-tagged LldR was miniprepped using the Promega SV miniprep kit. The concentrations of isolated plasmid are given below: | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Plasmid | !Plasmid | ||
!Concentration [ng/µl] | !Concentration [ng/µl] | ||
Line 289: | Line 338: | ||
Cut of the parts consisting the genes, LuxI (<partinfo>Bba_C0061</partinfo>) and LuxR+term (<partinfo>BBa_C0062</partinfo>, <partinfo>BBa_B0015</partinfo>), and extracted the DNA from the gel. Concentrations are listed below. | Cut of the parts consisting the genes, LuxI (<partinfo>Bba_C0061</partinfo>) and LuxR+term (<partinfo>BBa_C0062</partinfo>, <partinfo>BBa_B0015</partinfo>), and extracted the DNA from the gel. Concentrations are listed below. | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!BioBrick | !BioBrick | ||
!Enzymes | !Enzymes | ||
Line 306: | Line 355: | ||
Ligation mixes were made according to [https://2012.igem.org/Team:NTNU_Trondheim/Protocols protocol] with the following ingredients, as well as religation of the backbones: | Ligation mixes were made according to [https://2012.igem.org/Team:NTNU_Trondheim/Protocols protocol] with the following ingredients, as well as religation of the backbones: | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Backbone | !Backbone | ||
!Insert | !Insert | ||
Line 329: | Line 378: | ||
10 µl of the liquid cultures for K+RBS+colicin and LuxR+DTT was transferred to 5 ml of new liquid medium to be used in testing of the colicin biobrick. The rest of the samples were miniprepped using the Promega SV Miniprep kit. The concentrations of the samples are given below: | 10 µl of the liquid cultures for K+RBS+colicin and LuxR+DTT was transferred to 5 ml of new liquid medium to be used in testing of the colicin biobrick. The rest of the samples were miniprepped using the Promega SV Miniprep kit. The concentrations of the samples are given below: | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Biobrick | !Biobrick | ||
!Concentration [ng/µl] | !Concentration [ng/µl] | ||
Line 349: | Line 398: | ||
Did a restriction digest on the following biobricks, as described in the [https://2012.igem.org/Team:NTNU_Trondheim/Protocols protocol]. | Did a restriction digest on the following biobricks, as described in the [https://2012.igem.org/Team:NTNU_Trondheim/Protocols protocol]. | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Biobricks | !Biobricks | ||
!BioBrick no. | !BioBrick no. | ||
Line 384: | Line 433: | ||
The concentrations on the purified parts are as follows: | The concentrations on the purified parts are as follows: | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Biobricks | !Biobricks | ||
!BioBrick no. | !BioBrick no. | ||
Line 414: | Line 463: | ||
The concentrations were as follows: | The concentrations were as follows: | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Biobrick | !Biobrick | ||
!Concentration ng/uL | !Concentration ng/uL | ||
Line 445: | Line 494: | ||
The following primers were used: | The following primers were used: | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Primer | !Primer | ||
!Sequence | !Sequence | ||
Line 457: | Line 506: | ||
The PCR machine was programmed according to the following table: | The PCR machine was programmed according to the following table: | ||
- | {| class=" | + | |
+ | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" | ||
!Step | !Step | ||
!Action | !Action | ||
Line 509: | Line 559: | ||
Performed miniprep on RBS (<partinfo>BBa_B0030</partinfo>) and plld+RBS. The concentration were as follows: | Performed miniprep on RBS (<partinfo>BBa_B0030</partinfo>) and plld+RBS. The concentration were as follows: | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Biobrick | !Biobrick | ||
!Concentration ng/uL | !Concentration ng/uL | ||
Line 523: | Line 573: | ||
Did a restriction digest as described in the [https://2012.igem.org/Team:NTNU_Trondheim/Protocols protocol] on the following parts. On the pieces to be used as inserts, the number of base pairs are also listed. | Did a restriction digest as described in the [https://2012.igem.org/Team:NTNU_Trondheim/Protocols protocol] on the following parts. On the pieces to be used as inserts, the number of base pairs are also listed. | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Biobrick/Construct | !Biobrick/Construct | ||
!BioBrick | !BioBrick | ||
Line 592: | Line 642: | ||
Ligated together the following, as described in [https://2012.igem.org/Team:NTNU_Trondheim/Protocols protocols]: | Ligated together the following, as described in [https://2012.igem.org/Team:NTNU_Trondheim/Protocols protocols]: | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Ligation # | !Ligation # | ||
!Backbone | !Backbone | ||
Line 613: | Line 663: | ||
3A assembly was used on the following parts, as described in the [https://2011.igem.org/Team:Northwestern/Notebook/Protocols/3A_Assembly Protocol], by Northwestern University: | 3A assembly was used on the following parts, as described in the [https://2011.igem.org/Team:Northwestern/Notebook/Protocols/3A_Assembly Protocol], by Northwestern University: | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Ligation # | !Ligation # | ||
!Backbone | !Backbone | ||
Line 665: | Line 715: | ||
Miniprepped VHB+RBS+lysis (<partinfo>BBa_K258005</partinfo>, <partinfo>BBa_B0034</partinfo> and <partinfo>BBa_K112808</partinfo>), VGB+RBS+lysis (<partinfo>BBa_K561001</partinfo>, <partinfo>BBa_B0034</partinfo> and <partinfo>BBa_K112808</partinfo>), pllD+lysis (lactate promoter and <partinfo>BBa_K112808</partinfo>) and three parallels of pBad+YFP (<partinfo>Bba_K206000</partinfo> and <partinfo>BBa_E0030</partinfo>) | Miniprepped VHB+RBS+lysis (<partinfo>BBa_K258005</partinfo>, <partinfo>BBa_B0034</partinfo> and <partinfo>BBa_K112808</partinfo>), VGB+RBS+lysis (<partinfo>BBa_K561001</partinfo>, <partinfo>BBa_B0034</partinfo> and <partinfo>BBa_K112808</partinfo>), pllD+lysis (lactate promoter and <partinfo>BBa_K112808</partinfo>) and three parallels of pBad+YFP (<partinfo>Bba_K206000</partinfo> and <partinfo>BBa_E0030</partinfo>) | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Sample | !Sample | ||
!Concentration [ng/µl] | !Concentration [ng/µl] | ||
Line 753: | Line 803: | ||
The constructs containing plld ligated with the lysis device(<partinfo>BBa_K112808</partinfo>), and plld in plasmid <partinfo>PSB1C3</partinfo> were miniprepped. The concentration were measured using nano drop. | The constructs containing plld ligated with the lysis device(<partinfo>BBa_K112808</partinfo>), and plld in plasmid <partinfo>PSB1C3</partinfo> were miniprepped. The concentration were measured using nano drop. | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Sample | !Sample | ||
!Concentration [ng/µl] | !Concentration [ng/µl] | ||
Line 783: | Line 833: | ||
PCR was performed on pBad (<partinfo>Bba_K206000</partinfo>) and DTT (<partinfo>BBa_B0015</partinfo>), the primers used, PCR-mix and programmed times are listed below. | PCR was performed on pBad (<partinfo>Bba_K206000</partinfo>) and DTT (<partinfo>BBa_B0015</partinfo>), the primers used, PCR-mix and programmed times are listed below. | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Primer | !Primer | ||
!Type | !Type | ||
Line 833: | Line 883: | ||
{| | {| | ||
| style="padding-right:7px;" | | | style="padding-right:7px;" | | ||
- | {|class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
|+pBAD | |+pBAD | ||
! Step | ! Step | ||
Line 894: | Line 944: | ||
| style="padding-left:7px;" | | | style="padding-left:7px;" | | ||
- | {|class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
|+ DTT | |+ DTT | ||
! Step | ! Step | ||
Line 953: | Line 1,003: | ||
|} | |} | ||
|} | |} | ||
+ | |} | ||
+ | |||
+ | |||
+ | {{:Team:NTNU_Trondheim/Templates/Sponsors}} | ||
+ | <html> | ||
+ | </div></div></div></html> | ||
+ | {{:Team:NTNU_Trondheim/Templates/Footer}} |
Latest revision as of 22:03, 26 September 2012